Skip to content
Trial Eligibility
Menu

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

NCT07817251

This study is recruiting at 37 US sites in 16 states, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this clinical study is to look at the safety and tolerability of switching from semaglutide to CagriSema, for participants who have type 2 diabetes. All participants will get CagriSema, the treatment being tested. Participants will be in this clinical study for about 6 months.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Diabetes Mellitus, Type 2

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Sponsor
Novo Nordisk A/S
Last updated on ClinicalTrials.gov
September 30, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Arizona · 1

  • Gilbert Center For Family Medicine · Gilbert, AZ

California · 8

  • Ark Clinical Research · Fountain Valley, CA
  • Thrive Clinical Research Group · Glendora, CA
  • Scripps Whittier Diabetes Inst · La Jolla, CA
  • Downtown LA Res Ctr. Inc. · Los Angeles, CA
  • Valley Clinical Trials, Inc. · Northridge, CA
  • Dream Team Clinical Research · Pomona, CA
  • Clinical Trials Research_Sacramento · Sacramento, CA
  • Linda Vista Health Care Ctr · San Diego, CA

Connecticut · 1

  • Chase Medical Research LLC · Waterbury, CT

Florida · 5

  • Northeast Research Institute · Fleming Island, FL
  • AGA Clinical Trial · Hialeah, FL
  • Adult Medicine of Lake County, Inc · Mt. Dora, FL
  • Optimal Research Sites · Orange City, FL
  • Metabolic Research Institute Inc · West Palm Beach, FL

Hawaii · 1

  • East West Med Res Inst · Honolulu, HI

Illinois · 1

  • Endeavor Health · Skokie, IL

Iowa · 1

  • Iowa Diabetes & Endo Res Ctr · West Des Moines, IA

Kansas · 2

  • Alliance for Multispecialty Research · Newton, KS
  • Cotton O'Neil Diabetes & Endocrinology · Topeka, KS

Michigan · 1

  • Northern Pines Hlth Ctr, PC · Buckley, MI

Nevada · 1

  • Palm Research Center Inc-Vegas · Las Vegas, NV

New Mexico · 1

  • Albuquerque Clinical Trials Inc. · Albuquerque, NM

North Carolina · 2

  • PharmQuest Life Sciences LLC · Greensboro, NC
  • Accellacare Wilmington · Wilmington, NC

Tennessee · 1

  • Clinical Research Associates · Nashville, TN

Texas · 8

  • Amarillo Med Spec LLP · Amarillo, TX
  • Texas Diabetes & Endocrinology · Austin, TX
  • North Texas Endocrine Center · Dallas, TX
  • Diabetes and Thyroid Center of Fort Worth · Fort Worth, TX
  • JCCT- Juno NW Houston · Houston, TX
  • Sante Clinical Research · Kerrville, TX
  • DCOL Ctr for Clin Res · Longview, TX
  • North Hills Medical Research Inc · North Richland Hills, TX

Utah · 2

  • J.Lewis Research Inc · Salt Lake City, UT
  • Chrysalis Clinical Research · St. George, UT

Virginia · 1

  • Tidewater Physicians Multispecialty Group · Newport News, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.